Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Intestinal Diseases » Malabsorption Syndromes
Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Malabsorption Syndromes
Description
General term for a group of MALNUTRITION syndromes caused by failure of normal INTESTINAL ABSORPTION of nutrients. MeSH
Hierarchy View
Subtype Terms (9)
Celiac Disease
61 drugs (16 approved, 45 experimental)
Collagenous Sprue
1 approved drug
Hyperhomocysteinemia
17 drugs (10 approved, 7 experimental)
Lactose Intolerance
21 drugs (3 approved, 18 experimental)
Short Bowel Syndrome
45 drugs (29 approved, 16 experimental)
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (1)
Phase 3 Indicated Drugs (4)
Phase 2 Indicated Drugs (1)
Phase 1 Indicated Drugs (6)
Other Experimental Indicated Drugs (11)
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 3 Indications (7)
Organization Involved with Phase 2 Indications (8)
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (7)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
